세계의 티로신 키나아제 저해제 시장을 조사했으며, 시장 개요, 법규제 환경, 시장 영향요인 및 시장 기회 분석, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 특허·파이프라인의 동향, ESG 개발, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 서론
제2장 요약·하이라이트
시장 전망
시장 요약
제3장 시장 개요
키나아제 저해제
키나아제 저해제의 유형
티로신 키나아제 저해제
규제 시나리오
시장 역학
촉진요인
억제요인
기회
제4장 시장 내역 : 유형·용도별
티로신 키나아제 저해제 시장 : 유형별
수용체 티로신 키나아제 저해제
비수용체 티로신 키나아제 저해제
티로신 키나아제 저해제 시장 : 용도별
폐암
만성 골수성 백혈병(CML)
기타
제5장 시장 내역 : 지역별
세계의 티로신 키나아제 저해제 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제6장 ESG 개발
ESG : 개요
제조업체에 의한 지속가능성
제약 업계에서 최종사용자 지속가능성
사례 연구
BCC의 전망
제7장 산업 구조
상위 기업의 순위
파이프라인 분석
특허 분석
새로운 동향
제8장 기업 개요
ASTRAZENECA
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB CO.
EISAI CO. LTD.
F. HOFFMANN-LA ROCHE LTD.
JOHNSON & JOHNSON SERVICES INC.
NOVARTIS AG
PFIZER INC.
KSA
영문 목차
영문목차
Highlights:
This report provides a detailed understanding of the current market scenario for tyrosine kinase inhibitors and an assessment of the market’s growth over the period from 2023 through the end of 2028. The report highlights major trends and challenges that affect the global market and the vendor landscape.
Report Scope:
In this report, the market has been segmented based on type, application and geography. The report provides an overview of the global tyrosine kinase inhibitor market and analyzes market trends. Using 2022 as the base year, the report provides estimated market data for the forecast period of 2023 through 2028. Market values have been estimated based on the total revenue of tyrosine kinase inhibitor product providers.
The report covers the market for tyrosine kinase inhibitors with regard to the user base across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for tyrosine kinase inhibitors in 2022 and provides projections for the expected market size through 2028. The scope of the study includes tyrosine kinase inhibitor drugs that are already available in the market as well as future prospects.
Report Includes:
An overview of the global market for tyrosine kinase inhibitors
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Definition of tyrosine kinase inhibitors and their characteristics, and coverage of the market's dynamics, specifically drivers, inhibitors and opportunities
Discussions of novel tyrosine kinase inhibitors and their utility in the human trials
Examination of the technologies and methods used for the creation of novel targets and their therapeutic approaches
Discussions of market challenges and how to overcome them if the market is to reach its commercialization potential, pipeline drugs and relevant patents
Information on recent mergers and acquisitions, collaborations, partnerships and product introductions
Profiles of major players in the market
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Kinase Inhibitors
Types of Kinase Inhibitors
Tyrosine Kinase Inhibitors
Regulatory Scenario
Market Dynamics
Drivers
Restraints
Opportunities
Chapter 4 Market Breakdown by Type and Application
Market for Tyrosine Kinase Inhibitors, by Type
Receptor Tyrosine Kinase Inhibitors
Non-receptor Tyrosine Kinase Inhibitors
Market for Tyrosine Kinase Inhibitors, by Application
Lung Cancer
Chronic Myelogenous Leukemia (CML)
Others
Chapter 5 Market Breakdown by Region
Global Market for Tyrosine Kinase Inhibitors, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 ESG Development
Introduction to ESG
The Sustainability of Tyrosine Kinase Inhibitor Manufacturers in the Industry
